P61956 (SUMO2_HUMAN) Homo sapiens (Human)
Small ubiquitin-related modifier 2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
25 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Structure of SUMO-2 bound to phosphorylated RAP80 SIM |
Heteromer Q96RL1; | |||||
| Assess | ||||||
| Solution Structure of a SUMO-interacting motif of MBD1-containing chromatin-associated factor 1 bou… |
Heteromer Q6VMQ6; | |||||
| Assess | ||||||
| Structure of SENP2-Loop1 in complex with preSUMO-2 |
Heteromer Q9HC62; | |||||
| Assess | ||||||
| Crystal structure of human Senp2 in complex with preSUMO-2 |
Heteromer Q9HC62; | 3×SO4; | ||||
| Assess | ||||||
| Complex between human SUMO2-RANGAP1, UBC9 and ZNF451 |
Heteromer P46060; P63279; Q9Y4E5; | 3×EDO; | ||||
| Assess | ||||||
| Complex between human RanGAP1-SUMO2, UBC9 and the IR1 domain from RanBP2 containing IR2 Motif II |
Heteromer P46060; P49792; P63279; | |||||
| Assess | ||||||
| SENP1-SUMO2 complex |
Heteromer Q9P0U3; | |||||
| Assess | ||||||
| SENP1 covalent complex with SUMO-2 |
Heteromer Q9P0U3; | |||||
| Assess | ||||||
| Complex between human RanGAP1-SUMO2, UBC9 and the IR1 domain from RanBP2 |
Heteromer P46060; P49792; P63279; | |||||
| Assess | ||||||
| SUMO2 bound to phosphorylated SLS4-SIM peptide from ICP0 |
Heteromer P08393; | |||||
| Assess | ||||||
| Complex of SUMO2 bound SLS4 from ICP0. |
Heteromer P08393; | |||||
| Assess | ||||||
| Crystal Structure of SUMO-3-modified Thymine-DNA Glycosylase |
Heteromer Q13569; | |||||
| Assess | ||||||
| SUMO2 bound to Mouse Tdp2 catalytic domain with a 5'-phosphorylated DNA ternary complex |
Heteromer P61957; Q9JJX7; | 2×PO4; 2×EDO; 1×CL; | ||||
| Assess | ||||||
| Isoform-specific inhibition of SUMO-dependent protein-protein interactions |
Heteromer | |||||
| Assess | ||||||
| Mouse Tdp2 catalytic domain bound to SUMO2 |
Heteromer P61957; Q9JJX7; | 1×CA; 1×ACT; | ||||
| Assess | ||||||
| Isoform-specific inhibition of SUMO-dependent protein-protein interactions |
Heteromer | 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of human Senp2 in complex with RanGAP1-SUMO-2 |
Heteromer P46060; Q9HC62; | |||||
| Assess | ||||||
| Crystal structure of human tetra-SUMO-2 | homo-4-mer | |||||
| Assess | ||||||
| Crystal structure of human SUMO-2 protein | homo-3-mer | |||||
| Assess | ||||||
| Crystal structure of human SUMO-2 protein | homo-3-mer | |||||
| Assess | ||||||
| Solution Structure of Human Small Ubiquitin-Like Modifier Protein Isoform 2 (SUMO-2) | monomer | |||||
| Assess | ||||||
| Solution structure of human SUMO2 | monomer | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF LYS33 ACETYLATED HUMAN SUMO2 | monomer | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF LYS42 ACETYLATED HUMAN SUMO2 | monomer | |||||
| Assess | ||||||
| Solution Structure of Human SUMO-2 (SMT3B), a Ubiquitin-like Protein | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2n1w.1.A | monomer | 0.72 | 100.00 | |||
| Assess | ||||||
| 2rpq.1.A | monomer | 0.72 | 100.00 | |||
| Assess | ||||||
| 2n9e.1.B | monomer | 0.71 | 100.00 | |||
| Assess | ||||||
2 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 2n9e.1.B | monomer | 0.54 | 100.00 | ||
| Assess | ||||||
| Isoform 2 | 2awt.1.A | monomer | 0.51 | 100.00 | ||
| Assess | ||||||